Summary: Spreading depression (SD) confers either in creased susceptibility to ischemic injury or a delayed protec tion. Because nitric oxide modulates ischemic injury, we in vestigated if altered expression of nitric oxide synthase (NOS) by SD could account for the effect of SD on ischemia. Fur thermore, the identity of cells expressing NOS after SD is important, since SD results in heterogeneous, cell type-specific changes in intracellular environment, which can control NOS activity. Immunohistochemical, computer-based image analy ses and Western blotting show that the number of neuronal NOS (nNOS)-positive cells in the somatosensory cortex was significantly increased at 6 hours and 3 days after SD (P < 0.05 and 0.01, respectively), whereas inducible NOS expression reSince the discovery that nitric oxide (NO) is produced by neurons (Garthwaite et aI., 1988) and may function as a neurotransmitter (Bredt and Snyder, 1989; Garthwaite et aI., 1989) and a mediator of brain injury (Dawson et aI., 1991), much attention has been given to the cellular sources of this diffusible molecule. Cells produce NO through the action of at least three isoforms of nitric oxide synthase (NOS): neuronal (nNOS), inducible Abbreviations used: GFAP, glial fibrillary acidic protein; IR, immu noreactivity; LNAM, NA-nitro-L-arginine methyl ester; NO, nitric ox ide; NOS, nitric oxide synthase; iNOS, inducible nitric oxide synthase; nNOS, neuronal nitric oxide synthase; PBS, phosphate-buffered saline; PE, phenylephrine; PLP, sodium periodate-l ysine-HC1-paraformaldehyde fixative in phosphate buffer; PGT, phosphate buffered saline with Triton X-100; SD, spreading depression; SNP, sodium nitroprusside with phenylephrine.
Since the discovery that nitric oxide (NO) is produced by neurons (Garthwaite et aI., 1988) and may function as a neurotransmitter (Bredt and Snyder, 1989; Garthwaite et aI., 1989 ) and a mediator of brain injury (Dawson et aI., 1991) , much attention has been given to the cellular sources of this diffusible molecule. Cells produce NO through the action of at least three isoforms of nitric oxide synthase (NOS): neuronal (nNOS), inducible mained unchanged. Double-labeling of nNOS and glial fibril lary acidic protein identified these nNOS-positive cells as as trocytes. The effect of altered NO production on induced nNOS expression was examined by treating rats with sodium nitro prusside or N A -nitro-L-arginine methyl ester (LNAM) during SD. Increased nNOS expression was prevented by sodium ni troprusside and phenylephrine or phenylephrine alone, but not LNAM. Because SD increased astrocytic nNOS expression at time points correlating with both ischemic hypersensitivity and ischemic tolerance, the ability of SD to modulate ischemic injury must be complex, perhaps involving NOS but other fac tors as well. Key Words: Ischemia-Superoxide dismutase Spreading depression-Astrogliosis-Nitric oxide synthase.
(iNOS), and endothelial Zhang and Snyder, 1995) , Neuronal NOS is localized to discrete regions of the brain, where expression is exclu sive to neurons (Bredt et aI., 1991; Schmidt et aI., 1992) ; however, in the cerebellum and hippocampus, nNOS also is found in astrocytes (Schmidt et aI., 1992; Murphy et aI., 1993; Kugler and Drenckhahn, 1996) , In the neo cortex, nNOS is expressed in a small percentage of the total neurons, mostly residing in deeper lamina (Bredt et aI., 1991) . The observations that a subset of brain astro cytes can express nNOS (Schmidt et aI., 1992) and that nNOS mRNA could be isolated from astrocytes derived from many brain regions (Minc-Golomb and Schwartz, 1992) suggest that astrocytes throughout the brain may have the potential to express nNOS. Knowledge of where and under what circumstances they are able to express nNOS has important implications for understanding brain function under normal and pathologic conditions. Expression of the NOS isoforms is induced in many cell types after a variety of stimuli. Induction of iNOS expression occurs in hepatocytes after cytokine stimula tion (Geller et aI., 1993) , in the brain after cerebral isch emia (Iadecola et aI., 1995) , and throughout the body after lipopolysaccharide stimulation (Liu et aI., 1993) . Expression of iNOS increases in astrocytes after tran-sient global ischemia (Endoh et aI., 1994) and in both astrocytes and microglia in vitro after various types of perturbations (e.g., exposure to lipopolysaccharide and cytokines; Simmons and Murphy, 1992) . Expression of nNOS also is induced in neurons by events that cause cell death, such as peripheral nerve transection (Fiallos Estrada et aI., 1993; Verge et aI., 1992; Wu et aI., 1994) and cerebral ischemia (Zhang,. et aI., 1994a) .
Nitric oxide synthase activity modulates ischemic brain injury (Iadecola, 1997) . Intracellular conditions (e.g., Ca 2 +, pH) influence which NOS isoforms are ac tive. Because the intracellular conditions of glial cells can change dramatically during perturbations such as spreading depression (SD) and differ significantly from surrounding cells (Kraig and Chesler, 1988; Chesler and Kraig, 1989; Kraig and Lascola, 1994; Kraig et aI., 1995) , knowledge of which NOS isoforms can be ex pressed in glial cells is essential for understanding their potential contribution to NO production in brain. If neo cortical astrocytes or microglia could express multiple NOS isoforms after perturbation, this would diversify their potential roles in modulating neuronal injury. For example, damage after ischemia is reduced in nNOS deficient mice (Huang et aI., 1994; Panahian et aI., 1996; Hara et a!., 1996) . If glia express nNOS in vivo under conditions similar to ischemia (such as SD), they become a cellular site potentially involved in the earlier observa tion. Furthermore, several in vitro studies show that NO produced by iNOS in astrocytes (Hewett et aI., 1994) and microglia (Boje and Arora. 1992; Chao et aI., 1992 ) me diates neuronal cell death after excitotoxic injury. Thus, identifying NOS isoform expression in glia is essential for further understanding their role in normal and patho logic brain function.
Here we demonstrate that neocortical SD induces ex pression of nNOS in a subset of neocortical astrocytes. Spreading depression is a benign perturbation character ized by a propagating wave of electrical silence and negative interstitial direct current potential (Leao, 1944) . It is not associated with cellular injury (Nedergaard and Hansen, 1988; Kraig et aI., 1991) ; however, it does cause both astrocytes and microglia to become reactive (Kraig et aI., 1991; Gehrmann et aI., 1993; . In addition to transforming glia into reactive spe cies, SD induces the expression of enzymes that produce mediators of brain inflammation and injury (Caggiano et aI., 1996) . Since NOS manipUlation has been shown to modulate neuronal injury (Iadecola, 1997) , we sought to determine if SD might induce expression of the neuronal or inducible NOS isoforms, and if so, to determine the cellular source of this expression. We found that in the neocortex experiencing SD, nNOS expression was in duced within 6 hours, and expression was stronger at 3 days after SD. Spreading depression-induced expression was limited to astrocytes, but not all astrocytes within J Cereb Blood Flow Metab. Vol. 18. No. I, 1998 any given lamina expressed nNOS. In addition, in the course of determining if NO itself effected nNOS ex pression, we found that expression was blocked by treat ment of animals with phenylephrine (PE), an adrenergic agonist used in conjunction with agents that modulate NO production. These results demonstrate that a select population of astrocytes residing in the neocortex can express nNOS after noninjurious perturbation, and this expression can be prevented by adrenergic agonists.
METHODS

Animal preparation and recording
All procedures followed those of and Caggiano and others (1996) with some modifications. Ani mal preparation followed modified procedures of Kraig and coworkers (1991) and Moskowitz and associates (1993) . Fifty Wi star male rats (250 to 450 g; Harlan Sprague Dawley, In dianapolis, IN, and Charles River, Wilmington, MA, U.S.A.) were housed individually with food and water available ad libitum and maintained on a 12-hour light-dark schedule. Ani mals were fasted for 16 hours and then anesthetized by inha lation of halothane (5% induction, 3% during surgery, and 1.0% to 2.5% during electrophysiologic recordings) in a 20% oxygen-nitrogen gas mixture. Animals breathed spontane ously, and body temperature was maintained at 37 ± 0.5°C with a water body jacket.
Spreading depression was induced as previously described . Briefly, 0.5-to 8.0-second pulses (175 kPa) of 0.5 molfL KCI were injected into parietal neocor tex at 6 mm caudal to bregma and 4.5 mm left of the sagittal suture, every 9 minutes for 3 hours. Injections were made at a depth of 750 [Lm below the pial surface through glass micro pipettes (#6010 glass; A-M Corp., Everett, WA, U.S.A.) drawn to tip diameters of 12 [Lm. Recordings were made through two glass microelectrodes (#6030 glass; A-M Corp.) filled with 150 mmollL NaCI and with dip diameters of 2 to 8 [Lm. They were placed 3 mm rostral to bregma and 2 mm left and right of the sagittal suture at a depth of 750 [Lm. Recordings were amplified with an Axoprobe A-I system (Axon Instruments, Burlington, CA, U.S.A.), filtered at 2 Hz, and displayed on a chart recorder. The exposed skull was bathed in Ringer solution (1 to 3 mLl min) during recordings. Ringer solution contained the follow ing (in millimolar amounts): Na+ 143.5; K+ 3.0; Ca 2 + 1.5; Cl-115; HC03 -26.4; gluconate 9.6; and glucose 5.0; the Ringer solution had a pH of 7.3 to 7.4 when aerated with 95% oxygen and 5% carbon dioxide (modified from Bretag, 1969) . A tail artery was cannulated for the monitoring of arterial blood gas. Carbon dioxide tension (Paco2), oxygen tension (Pao2), and pH were measured every 30 to 60 minutes with a Corning blood gas analyzer (model 238; Ciba Coming Diag nostics, Medfield, MA, U.S.A.). Halothane levels were ad justed (0.5% to 1.5%) to maintain Paco2 between 50 to 75 mm Hg, a range consistent with adequate anesthesia (Kraig et aI., 1986) . Blood glucose also was measured during the recording procedures (Glucometer, Miles Laboratory, Naperville, IL, U.S.A.). After 3 hours of SD, electrodes were removed. Ani mals recovered for 6 hours or 3 days under environmental conditions described earlier.
Some animals were treated 1 hour before surgery with N Anitro-L-arginine methyl ester (LNAM; five animals), sodium nitroprusside with phenylephrine (SNP; five animals), or PE (three animals) alone. Both SNP and PE were purchased from Sigma (St. Louis, MO, U.S.A.) and LNAM from Merck Sharp and Dohme (West Point, PA, U.S.A.). The dosages were de rived from the literature . The LNAM was given at 30 mg/kg intraperitoneally in 0.01 mollL phosphate-buffered 150 mmollL NaCI (PBS; pH 7.4). All ani mals treated with drugs survived for 3 days after SO under conditions described earlier.
Phenylephrine and SNP were delivered according to the methods of Zhang et al. (l994b) The remaining steps followed those described earlier.
The NOS immunohistochemical study also was performed after absorption of the antibodies with peptides containing the sequences to which the antibodies were raised (l00, 10, and 1 ng peptide/mL; Santa Cruz Biotechnology). As a control, the nNOS antibody was preabsorbed to the iNOS peptide and the iNOS antibody preabsorbed to the nNOS peptide. Inducible nitric oxide synthase. Analysis of the iNOS image was performed according to the procedures of . Briefly, images were acquired as described ear lier, except that sections were transilluminated with an Intralux 4000 fiber-optic flat light source (Volpi MFG, Co., Auburn, NY, U.S.A.) through a 540/40 nm band pass filter. Images were acquired with the same CCD camera described earlier. Optical density of immunoreactivity (lR) was used to ana lyze the iNOS images according to the procedures described in detail in . Briefly, areas of interest were drawn around the left and right neocortex of each section, and the optical density was measured with light and dark limits set to values that encompass those found in each section. The IR for each section was reported as the log of the left side optical density divided by the right side optical density [log (lJr)]. In this manner, equal left and right staining intensities give a value of zero.
Computer-based image acquisition
Data analysis
The ubiquitous expression levels of iNOS in the areas of interest allowed densitometry analyses. Variations in back ground staining were eliminated by comparison of left and right neocortices. The lower expression level of nNOS in the outer three layers of the neocortex meant that positively stained cells could be accurately counted. Furthermore, this lower expres sion level meant that densitometric analyses would be domi nated by background staining. Therefore, object counting analysis was used.
The operator was blind to the experimental group of each animal during data acquisition and data analysis. Furthermore, during staining procedures, sections from different groups al ways were processed together and no group was processed entirely at one time. In this manner, the possibility that group differences resulted from differences in processing of tissues was minimized.
Photomicrographs were prepared using the CCD camera and software described earlier. Images were taken at x60 (total magnification) through 630/40 (Fig. 6 ) or 480/40 nm (all oth ers) band pass filters. Images were reference-corrected (as be fore) and higauss filtered (7 x 7 pixel matrix, 50% strength, two passes; Image Pro Plus software). Figures were compiled and labeled using Adobe Photoshop 4.0 software (Adobe Systems, Inc., San Jose, CA, U.S.A.) and printed on a dye-sublimation printer (XLT-7720; Eastman Kodak, Rochester, NY, U.S.A.). Scale bars are as indicated in figure legends.
Western blots
Given the novel nNOS expression pattern induced by these experimental procedures, we believed it necessary to confirm the specificity of the nNOS antibody by Western blot analysis on samples of rat neocortex. Adult rats-matched for age, size, and sex (used above)-were deeply anesthetized with halo thane and decapitated. Brains were rapidly removed. The cor tices were cut away and frozen in powdered dry ice.
Western blot procedures followed those described in Sam brook and coworkers (1989). Neocortical sections weighing approximately 100 mg were washed with cold PBS and then mechanically dissociated in suspension buffer containing pro tease inhibitors. Gel loading buffer was added, and samples were boiled for 5 minutes and underwent sonification for 2 minutes. Samples and protein markers were run on standard 7.5% SDS-polyacrylamide gel (Laemmli, 1970) using Heofer mini-gel systems (Hoefer Scientific Instruments, San Francis co, CA, U.S.A.).
Proteins were transferred to nitrocellulose membranes and incubated overnight with nNOS or iNOS antibody. Some mem branes were incubated with antibodies preabsorbed with NOS peptides. Membranes were washed and incubated with an anti rabbit HRP-Iabeled antibody. Protein-antibody products were visualized using the ECL Western blotting analysis system (Amersham Life Science, Arlington Heights, IL, U.S.A.) and X-OMAT XAR-5 film (Eastman Kodak Co. adjusted for brightness and contrast (normal and control lanes were treated identically).
RESULTS
The experimental procedures described earlier reliably induced SD in the left neocortex but never induced SD in the right control neocortex. An example of the left and right neocortical electrical activity recorded during SD is shown in Fig. 1 . The top trace of each pair was recorded from the left neocortex. The bottom trace is from the right neocortex. No SD were induced in sham-operated animals. After recovery from anesthesia, animals showed normal feeding, grooming, and motor activity. Blood physiologic variables (Table 1) The nNOS-positive neurons were distributed to dis crete brain regions. Overall, nNOS IR filled large, mul tiprocessed neurons consistent with previous observa tions . In neocortex, these large neurons were distributed throughout the neocortex, but most of the nNOS-positive cells were found in deeper lamina and made up only a small percentage of the total population ( Fig. 2A and B) . The iNOS IR in the neocor-
Electrophysiologic recordings of spreading depressions (SO) in the left (top trace of each pair) and right (bottom trace) frontal neocortices. Direct current (�C) potentials are shown dur ing 3 hours of recurrent SO induced by microinjection of 0.5 molll KCl into parietal cortex every 9 minutes. Scale bar = 20 mV. Spreading depressions were observed only in the experimental left neocortex. Sham-operated animals received 0.5 mol/l NaCI injections, and SO were never observed. After recordings, ani mals survived for 6 hours or 3 days and then were processed for NOS immunohistochemical study. 37.3 ± 0.4 1.2 ± 0.6 13 ± 3* 9.3 ± 1.6* 37.1 ± 0.6 1.4 ± 0.1 19 ± I
6.4 ± 0.8 37.7 ± 0.6 1.5 ± 0.2 19 ± 3 5.3 ± 0.6 * Indicates significantly different from other groups according to analysis of variance and post-hoc Tukey. All groups contain three to five animals.
tex was localized to large, processed cells in all layers of neocortex ( Fig. 2C and D) . Figure 2A and B show nNOS IR in the superficial and deeper layers or neocortex, re spectively, in a normal rat. Normal iNOS IR is similarly shown in Fig. 2C and D. A higher power (x 100) photomicrograph of the super ficial neocortex from a normal animal processed for nNOS IR (Fig. 3) shows that nNOS is expressed at ex tremely low levels in cells that have the general morpho logic makeup of astrocytes. The top arrow points to an astrocyte process, the middle arrow indicates the cell body, and the bottom arrow points to a possible end-foot process on a blood vessel.
Neuronal nitric oxide synthase expression is induced at 6 hours after spreading depression Six hours after SD, a population of cells became nNOS-positive in the superficial lamina of the neocortex experiencing SD. These cells were small, finely pro cessed, and numerous (Fig. 4A) . The nNOS expression level in this population of cells was much more intense than that found in the contralateral, control neocortex (data not shown; however, for comparison see Figs. 2A and 3). Computer-based cell counting was used to show a significant elevation at 6 hours after SD in the number of positively stained objects in the superficial lamina of the left neocortex compared with either the right neocor tex of SD animals or the left neocortex of normal animals (P < 0.05). Objects were defined as cell bodies or large processes above a given size and intensity threshold (see Methods) . No significant differences between the num ber of positive cells in control neocortices of experimen tal animals and neocortices of sham-operated or normal animals were seen (P >0.05; data not shown). The nNOS-positive cells found in the deeper layers of the left, experimental neocortices were not different from those found in normal animals.
Neuronal nitric oxide synthase expression is elevated at 3 days after spreading depression At 3 days after SD, nNOS IR displayed a similar, but more intense, expression pattern to that at 6 hours after SD. Again, a population of small, finely processed cells expressed nNOS in the outer (Fig. 5) but not the deeper lamina of the neocortex. Computer-based cell counting revealed a significant difference between the number of positively stained cells in the left neocortex of experi mental animals compared with either left neocortex of normal animals or right neocortex of experimental ani-J Cereb Blood Flow Metab, Vol. 18, No. 1, 1998 mals (P < 0.01; Fig. 6A) . No left-versus-right difference was found in normal or sham-operated animals.
The iNOS expression was not induced at 6 hours ( Fig.  4B ) or 3 days after SD. At 3 days, expression patterns were identical to normal and sham-operated animals (data not shown). Computer-based optical density analy sis confirmed this point. The widespread and even ex pression pattern of iNOS (compared with nNOS) al lowed for densitometric analyses (see Methods: Data analysis).
Western blot and competition assays
To confirm the specificity of the antibodies, we per formed Western blot analysis using the nNOS and iNOS antibodies on extracts from normal rat neocortex. The nNOS and iNOS antibodies revealed a positive band, each occurring at the appropriate weight (-150 kd and -130 kd, respectively; Fig. 7 , right-hand column). A smaller peptide (nNOS: -25 kd; iNOS: -40 kd) also stained positive with each antibody. To determine if this was a degradation product or if the antibody was reacting with another peptide, we preabsorbed the antibodies with peptides (l00 ng/mL) from their corresponding NOS protein. Both bands detected by each antibody were com pletely blocked by the appropriate peptide (Fig. 7) , con firming that the antibodies were specific for their in tended target.
Furthermore, each antibody was tested by the ability of the nNOS and iNOS peptides to block their IR in the tissue sections. The nNOS IR was completely blocked by preabsorption of the antibody with 100 or 10 ng/mL nNOS peptide, and partially blocked by 1 ng/mL peptide (Fig. 7) . No blocking occurred after preabsorption with 100 ng/mL iNOS peptide (not shown). Similar blocking results were obtained when iNOS antibody was absorbed with iNOS peptide (Fig. 7) . No blocking of iN OS IR occurred with absorption with nNOS peptide.
Neuronal nitric oxide synthase/glial fibrillary acidic protein double-labeling
The appearance of finely processed small nNOS positive cells (Fig. 5) suggested that they may be astro cytes. Double-staining with nNOS antibody and an an tibody against GF AP revealed that most cells that stained nNOS-positive in the outer layers of neocortex after SD also were GFAP-positive. A photomicrograph showing nNOS (green) and GFAP (red) staining is shown in Fig.  8 , using a xlOO objective under oil immersion (total magnification x630). All nNOS-positive cells (other than the larger neuronal cells appearing in normal and SD sections) stained GFAP-positive; however, many astro cytes (GFAP-positive cells) did not express nNOS. Ob serve that there are three nNOS-positive cells in Fig. 8 (center, center right. , and bottom left). Each also is GFAP-positive (red staining).
FIG. 4.
Photomicrographs of nNOS (A) and iNOS (8) immunohistochemical features at 6 hours after SO. Each micrograph is taken as in previous figures from the experimental, left neocortex. Images were taken at x60. Scale bars = 300 I lm. Notice in A that nNOS is strongly expressed in small cells bearing fine processes that are not seen in normal animals (compare with Fig. 2A) . Computer-based cell counting revealed a significant increase (P < 0.05) in the number of nNOS-positive objects compared with normal animals (Fig. SA) . No change was observed in deeper lamina, or in the control, right neocortex. The iNOS expression was unchanged at 6 hours after SO. Some variation in iNOS background staining is seen between Figs. 2 and 4 ; however, these micrographs do not represent any trend toward increased staining with SO. This was confirmed by densitometric analysis.
Sodium nitroprusside and LNAM effects
To determine if NO itself might effect the expression of nNOS, as has been observed with iNOS expression (Guo et aI., 1995) , we treated animals before SD surgery with agents that inhibit (LNAM) NO production or non enzymatically (SNP) donate NO. The nNOS cell counts from groups treated pharmacologically (LNAM, SNP, or PE) before and during SD were compared with ipsilateral neocortical cell counts from the group receiving SD without any pharmacologic manipulation. nNOS positive cell counts in the experimental cortex of the group treated with the combination of SNP and PE were sig nificantly less than those from the SD group (P < 0.01; Figs. 6B and 9) . The group treated with PE only also had significantly lower cell counts (P < 0.05; Figs. 6B and 9) . Cell counts from the LNAM group were not significantly different from the SD counts (Figs. 6B and 9 ). These observations are evident histologically in the photomi crographs displayed in Fig. 9 . Notice in the photomicro graphs taken from the SNP and PE groups that the dis tribution of nNOS-positive cells is indistinguishable from that of the normal group (Figs. 2A) . Furthermore, nNOS-positive cells in the LNAM group appear similar in number, morphologic features, and distribution to those from the SD group (Figs. 5, 6B , and 9).
DISCUSSION
The primary observation of this work is that expres sion of the neuronal isoform of NOS can be induced in FIG. 5 . Photomicrograph demonstrating nNOS immunohisto chemical features at . 3 days after SO in the experimental left neocortex. Image was taken at x60. Scale bars = 300 Ilm. Notice that nNOS-positive cells in the outer lamina of neocortex are not present in normal brain. This distribution was similar to that at 6 hours (Fig. 4A) ; however, the nNOS-positive cells were more intensely stained at 3 days than at 6 hours. Again, no changes in the number, morphologic features, or intensity of nNOS-positive cells were seen in the deeper lamina of neocortex, or in the control, right cortices. Quantitation of these changes is found in Fig. 6A . Because iNOS expression was the same in normal, 6-hour post-SO, and 3-day post-SO animals, further iNOS photo micrographs are not shown. Snyder, 1994; Zhang and Snyder, 1995) . The NOS iso form responsible for NO production in astrocytes and microglia generally has been shown to be iNOS (Murphy et al.. 1993) . Expression of iNOS in astrocytes has been shown to be enhanced after various neuropathologic con ditions (Endoh et aI., 1994; 80 et aI., 1994; Nakashima et aI., 1995) . In the cerebellum and hippocampus, nNOS expression also has been demonstrated in astrocytes (Murphy et aI., 1993; Kugler and Drenckhahn, 1996) ; however, in the neocortex, nNOS is expressed exclu sively to a small number of neurons (Schmidt et aI., 1992) . The observation that nNOS mRNA could be iso lated from astrocytes in many regions outside of the cer ebellum (Mine-Golomb and Schwartz, 1992) suggests that astrocytes could be induced to express nNOS else where in the brain. In the current results, the morpho logic features of the cells that were induced to express nNOS after SD (Fig. 5) had the general appearance of astrocytes. Double-labeling with antibodies raised against GFAP and nNOS confirmed that this novel ex pression of nNOS was limited to astrocytes (Fig. 8) .
Thus. whereas a few neurons residing in the deepest three layers of neocortex strongly express nNOS and perhaps some astrocytes weakly express nNOS (Fig. 3) in normal (non-SD) brain, after SD a large population of Notice that nNOS immunore activity (IR) was completely blocked by 100 ng/mL peptide. Nearly com plete and partial blocking also was achieved with 10 and 1 ng/mL pep tide, respectively. Images were taken at x60. Scale bar = 300 j.Jm. On the far right are Western blots of normal rat neocortex extract using the nNOS (top) and iNOS (bottom) antibody. Right-hand lanes are blots using the antibodies that were preabsorbed with 100 ng/mL peptide. The nNOS antibody detected bands at -150 kd and -25 kd; the iNOS antibody de tected bands at -130 kd and -50 kd. Each of these bands were almost completely blocked by preabsorption. astrocytes in the superficial layers of neocortex also strongly express nNOS. Spreading depression induces reactive gliosis in both astrocytes (Kraig et aI., 1991) and microglia (Gehrmann et aI., 1993; . To confirm that these cells were not microglia, we double-labeled tissue sections with the nNOS antibody and the GSA IB-4 isolectin (a marker of microglia in the CNS). Cells ex pressing nNOS after SD do not stain positively with the isolectin, demonstrating that they are not microglia (data not shown).
Given the novel expression pattern of the nNOS anti body in neocortical astrocytes after SD, we sought to confirm its specificity for the nNOS isoform by perform ing Western blots on extracts from rat neocortex. The nNOS antibody was extremely clean, detecting a band at the expected -150 kd and a smaller band at -25 kD (Fig.  7) . We confirmed that the smaller band likely \yas a degradation product of nNOS by demonstrating that pre absorption of the nNOS antibody with 100 ng/mL of a nNOS peptide completely blocked the interaction of the antibody with both of these bands (Fig. 7) . Furthermore, this peptide was able to block nNOS reactivity in brain sections at 10 ng/mL (Fig. 7) , whereas an iNOS peptide was unable to block nNOS reactivity at any concentra tion tested. We believe these important controls, in ad-
Composite digital photomicrograph showing correspon dence of nNOS (green) and glial fibrillary acidic protein (GFAP; red) staining from an animal 3 days after SD. The nNOS immu nohistochemical study was performed as described in the Meth ods. The GFAP staining then was performed on the same sec tions using a rhodamine-labeled secondary antibody. A bright field (nNOS) and a fluorescent (GFAP 570-nm excitation, 590-nm emission) image were taken of the same field, higauss filtered and superimposed. The nNOS-positive cells in the outer layers of neocortex also stained GFAP-positive in the 3-day post-SD ani mals. This confirms by morphologic and immunohistochemical study that the novel nNOS-positive cells are astrocytes.
dition to the nNOS/GFAP double-labeling, strongly sup port the conclusion that the novel expression detected by the nNOS antibody after SD is indeed the neuronal iso form of NOS localized to neocortical astrocytes. It is unclear why only a fraction of the astrocytes in the superficial lamina of the neocortex express nNOS after SD. Differential expression of receptors and channels on astrocytes occur in anatomically distinct zones of the brain (Van der Zee et aI., 1993) and functionally unique regions, such as at nodes of Ranvier (Black et aI., 1989) . Astrocytes also display morphologic diversity based on their laminar localization (Bailey and Shipley, 1993) . Here, however, we observe that only a subset of astro cytes within a given lamina and functional zone of neo cortex express nNOS in response to SD, whereas at least an equal number remain nNOS-negative. After SD, most or perhaps all astrocytes within this region become re active, as demonstrated by their change in morphologic features and GFAP IR (Kraig et aI., 1991; . Perhaps astrocytes within the neocortex have functional subtypes. On the other hand, perhaps these nNOS-positive astrocytes are responding to local ized differential activity of the immediately adjacent neurons, resulting in differential enzyme expression.
Astrocytes undergo dynamic changes in intracellular calcium concentration that may regulate the activity of the calcium-dependent nNOS. Astrocytes experience de polarization-dependent calcium fluxes during SD that exceed 1 f.LmollL (Kraig et aI., 1995) . Changes in cal cium concentration in this range have been shown to stimulate nNOS to near maximal activity (Bredt and Snyder, 1990) . Intracellular calcium concentration in as trocytes also is responsive to a variety of transmitters. Glutamate and certain agonists cause increases in intra cellular calcium in primary cultured astrocytes (Enkvist et aI., 1989a; Chiu, 1990 and Glaum et aI., 1990; van den Pol et aI., 1992) and in astrocytes in hippocampal organotypic cultures (Dani et aI., 1992) . Phenylephrine, carbachol (Enkvist et aI., 1989b) , and se rotonin (van den Pol et aI., 1992) also induce intracellu lar calcium responses in astrocytes. Thus, despite the fact that application of N-methyl D-aspartate to cultured as trocytes produces no calcium flux (Jensen and Chiu, 1990) , astrocytes clearly undergo intracellular calcium changes in response to their electrical and chemical en vironment. These changes make them a potentially ideal site for differential regulation of nNOS, which may in turn affect how astrocytes and NO contribute to brain injury and recovery. Induction of nNOS expression in glia may have im portant and probably complex implications in the patho genesis of ischemic brain injury. Increased expression of nNOS in neurons is induced by cerebral ischemia (Zhang et aI., 1994a) . Furthermore, NO is thought to mediate resultant brain damage, since nNOS-specific inhibitors ameliorate ischemic damage (Zhang et aI., 1996) and nNOS mutant and knockout mice are resistant to isch emic brain injury (Panahian et aI., 1996; Hara et aI., 1996; Huang et aI., 1994; Dawson et aI., 1996) . Here we show that SD induces expression of nNOS in astrocytes (not neurons). Spreading depression is closely associated with injury from cerebral ischemia. For example, SD immediately before ischemia worsens the resultant cel lular damage (Takano et aI., 1996) ; however, when SD occurs days before ischemia, an "ischemic tolerance" develops, making the brain more resistant to irreversible cellular damage (Kobayashi et aI., 1995; Kawahara et aI., 1995; Matsushima et aI., 1996) . Furthermore, SD or SD like events occurring during focal cerebral ischemia within the penumbra correlate with the magnitude of resulting neural injury (Busch et aI., 1996; Mies et aI., 1993) . The fact that SD alone is able to induce nNOS expression (Figs. 4A and 5) , an enzyme known to be a key mediator of ischemic damage (Zhang et aI., 1996; Panahian et aI., 1996; Hara et aI., 1996; Huang et aI., 1994; Dawson et aI., 1996) , suggests that induction of nNOS expression in astrocytes is one mechanism by which SD may affect injury from ischemia.
Spreading depression may lessen or worsen the effects FIG. 9. Photomicrographs of nNOS immunohistochemistry at 3 days after SO in animals treated with sodium ni troprusside and phenylephrine (SNP), phenylephrine alone (PE), or NA-nitro-L-arginine methyl ester (LNAM). Images were taken at x60. Scale bar = 300 j.Jm. Notice that the SNP and PE images are nearly indis tinguishable from normal animals ( Fig. 2A) , whereas the LNAM image is similar to the 3-day animals without pharmacologic manipulation (Fig. 5) .
Computer-based object counting con firmed these impressions (Fig. 68) .
of subsequent ischemia through the control of the ex pression of other enzymes. One candidate enzyme is su peroxide dismutase. Expression of both the manganese and copper-zinc forms of superoxide dismutase were found to be decreased at 6 hours after SD, but dramati cally increased at 3 days after SD (Caggiano and Kraig, 1997) . The interaction of NO and superoxide is one means by which NO mediates brain injury (Lipton et a!., 1994; Beckman et aI., 1994) . Per oxynitrite COONO), formed from the combination of NO and superoxide (02-) (Huie and Padmaja, 1993) , is toxic to neurons (Lipton et aI., 1993) . Superoxide dis mutase scavenges O2-, preventing the formation of -OONO. Thus, it might be the combined effects and time course of altered nNOS and superoxide dismutase levels after SD that result in the initial sensitivity and subse quent tolerance to ischemia after SD (Caggiano and Kraig, 1997) . The ability to modulate the expression of NOS iso forms may allow for the regulation of their contribution to brain diseases such as ischemia. Furthermore, this in formation will help elucidate the signaling mechanisms that control their transcription, translation, or modifica tion into mature form. Nitric oxide itself is one cellular signal that controls the activity (nNOS; Rogers and Ig naITO, 1993) and expression (iNOS; Guo et aI., 1995) of NOS. To determine if modulation of NO production in the brain during SD might alter the expression of nNOS induced in neocortical astrocytes, we treated animals with LNAM, SNP, and PE, or PE alone. LNAM (an L-arginine analogue), which should prevent the forma tion of NO, had no effect on the induced expression of nNOS. Treatment of animals with SNP (a nonenzymatic NO donor) plus PE completely blocked the induced ex pression of nNOS (Figs. 6B and 9) . Phenylephrine was given to animals receiving SNP to maintain blood pres sure, which would otherwise have fallen with the dona tion of NO. Because the SNP/PE control (PE alone) also blocked nNOS expression in astrocytes, no conclusions can be drawn regarding the influence of SNP and NO; however, we can conclude that induction of nNOS ex pression is prevented by the adrenergic agonist, an ob servation also seen in the expression and activity of iNOS (Feinstein et aI., 1993) . The fact that expression can be completely blocked by an agent analogous to endogenous transmitters within the brain shows encour aging potential for our ability to control NOS expression during brain diseases.
The prevention of nNOS expression by PE alone was an unexpected result of this study. There is a limited body of literature regarding adrenergic agonists and NOS expression, and we are aware of no reports examining NOS activity or expression using an alpha-l specific agonist such as PE. Alpha-l receptors do mediate inosi tolphosphate and Ca 2 + signaling in astrocytes (Biber et aI., 1996; Enkvist et aI., 1989b) and thus may modulate NOS activity and, in turn, NOS expression. Astrocytosis is regulated by beta-adrenergic receptors (Griffith and Sutin, 1996; Hodges-Savoia et aI., 1996) and glutamine uptake by astrocytes is regulated by alpha-and beta adrenergic agonists (Huang and Hertz, 1995) . However, we have previously shown that astrogliosis is not pre vented by PE or SNPIPE ; thus, the reduced nNOS expression is not the result of preventing astrogliosis in general. Further analysis of the possible mechanisms by which PE prevents nNOS ex pression is needed but beyond the scope of this report.
In conclusion, we demonstrated that expression of the neuronal isoform of NOS is able to be induced in neo cortical astrocytes by SD. This induction is rapid (by 6 hours) and sustained (3 days). It can be blocked by the adrenergic agonist PE. We found no increase in iNOS expression after SD; however, Western blot analysis and competition studies demonstrated the efficacy of the an tibody. These results show that astrocytes are able to express nNOS in the neocortex and introduce another factor in the surely complex mechanism by which SD alters resultant damage from ischemia.
